8.63
1.89%
0.16
Anavex Life Sciences Corporation (AVXL) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
12.55%
1.756
|
2.008 | 1.9582 | 1.8279 | 1.4652 |
Operating Expenses
|
10.86%
12.52
|
11.29 | 12.65 | 13.53 | 14.19 |
Benefits Costs and Expenses |
15.67%
12.20
|
10.54 | 12.17 | 13.07 | 14.52 |
Costs And Expenses |
15.67%
12.20
|
10.54 | 12.17 | 13.07 | 14.52 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
10.86%
-12.52
|
-11.29 | -12.65 | -13.53 | -14.19 |
Net Interest Income/Expense |
12.55%
1.756
|
2.008 | 1.9582 | 1.8279 | 1.4652 |
Nonoperating Income/Loss |
24.60%
2.078
|
2.756 | 2.4422 | 2.2917 | 1.1319 |
Income/Loss From Continuing Operations Before Tax |
22.30%
-10.44
|
-8.537 | -10.21 | -11.24 | -13.06 |
Income Tax Expense/Benefit, Current |
23.53%
0.105
|
0.085 | -0.064 | 0.041 | 0.05 |
Income Tax Expense/Benefit |
23.53%
0.105
|
0.085 | -0.057 | 0.041 | 0.05 |
Income/Loss From Continuing Operations After Tax |
22.32%
-10.55
|
-8.622 | -10.15 | -11.28 | -13.11 |
Net Income/Loss
|
22.32%
-10.55
|
-8.622 | -10.15 | -11.28 | -13.11 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.47%
82.46
|
82.08 | - | - | - |
Diluted Average Shares |
0.47%
82.46
|
82.08 | - | - | - |
Basic Earnings Per Share |
18.18%
-0.13
|
-0.11 | - | - | - |
Diluted Earnings Per Share |
18.18%
-0.13
|
-0.11 | - | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):